Nova Eye Medical Share Price and Company Fundamentals



Price
$0.32
Change
-0.010 (-3.030%)
52 week
0.285 - 0.79

Last traded: Today at 2:12 AM

Nova Eye Medical Limited designs, manufactures, distributes, and services medical equipment and devices to diagnose and treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with openangle glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, rest of Asia, South America, and internationally. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.

Key Metrics

PE ratio

1.25

PB ratio

1.24

Dividend yield

Beta

0.61

Market cap

$45.98M

Enterprise value

$21.12M

Company profile

Primary activitiesMedical devices manufacturer.
Industry / SectorMedical Devices / Healthcare
Websitehttp://www.nova-eye.com
Mailing address107 Rundle Street Kent Town SA 5067 Australia
Phone / Fax /
Share registryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Dividends

Nova Eye Medical does not pay dividends.

Company Executives

As of May 2021, following are the company executives and directors listed on Nova Eye Medical.

NameTitleAgeTotal Pay
Mr. Victor Previn B.E., B.EngFounder & Exec. Chairman62247.38k
Ms. Kimberley MenziesGroup Financial Controller & Global Fin. Mang.
Mr. Keith ByrneVP of Global Operations
Dr. Thomas Duthy M.B.A., Ph.D.Head of Investor Relations & Corp. Devel.
Ms. Kate HuntHead of Marketing
Mr. Thomas H. SpurlingConsultant & Director58
Dr. David Lubeck M.D.Chief Medical Officer
Mr. Bill SwaimPres of Laserex IS Ellex (USA)
Mr. Joaquin V. WolffPres of Ellex iTrack62
Mr. Simon Jeremy Newton Gray C.A., BEc, CACompany Sec.61

Profitability and management effectiveness

Profit margin

288.68%

Operating margin

-43.32%

Return on assets

-4.60%

Return on equity

-17.46%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Nova Eye Medical is 45.98M and its enterprise value is 21.12M. The enterprise value to revenue ratio of EYE is 1.66.

The EYE's stocks Beta value is 0.61 making it 39% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Nova Eye Medical (EYE)

Nova Eye Medical (ASX:EYE) Frequently Asked Questions

1. What is Nova Eye Medical's Stock Symbol?

Nova Eye Medical trades on ASX under the ticker symbol "EYE".

2. What is Nova Eye Medical's stock price today?

One share of EYE stock can currently be purchased for approximately $0.32.

3. How can I contact Nova Eye Medical?

Nova Eye Medical's mailing address is 107 Rundle Street Kent Town SA 5067 Australia. The company can be reached via phone at .

4. What is Nova Eye Medical's official website?

The official website of Nova Eye Medical is http://www.nova-eye.com.

5. Which share registry manages Nova Eye Medical's stock?

Nova Eye Medical's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.